share_log

HOOKIPA Pharma | 4: Statement of changes in beneficial ownership of securities-Director Kaufman David Ross

HOOKIPA Pharma | 4: Statement of changes in beneficial ownership of securities-Director Kaufman David Ross

HOOKIPA Pharma | 4：持股變動聲明-董事 Kaufman David Ross
美股SEC公告 ·  06/19 04:20

牛牛AI助理已提取核心訊息

David Ross Kaufman, a reporting person for HOOKIPA Pharma Inc. [HOOK], engaged in a transaction involving the company's stock on June 17, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. The address provided for Kaufman is associated with HOOKIPA Pharma's corporate offices in New York.
David Ross Kaufman, a reporting person for HOOKIPA Pharma Inc. [HOOK], engaged in a transaction involving the company's stock on June 17, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. The address provided for Kaufman is associated with HOOKIPA Pharma's corporate offices in New York.
HOOKIPA Pharma的一名報告人David Ross Kaufman於2024年6月17日進行了涉及該公司股票的交易。交易的具體細節，包括操作類型、狀態、涉及的股份數量、股份性質、交易價格和交易後的參股金融，未在公告中披露。Kaufman提供的地址與HOOKIPA Pharma在紐約的公司辦事處有關。
HOOKIPA Pharma的一名報告人David Ross Kaufman於2024年6月17日進行了涉及該公司股票的交易。交易的具體細節，包括操作類型、狀態、涉及的股份數量、股份性質、交易價格和交易後的參股金融，未在公告中披露。Kaufman提供的地址與HOOKIPA Pharma在紐約的公司辦事處有關。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間